Walleye Trading’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $9.18M | Sell |
42,217
-39,716
| -48% | -$8.81M | 0.02% | 833 |
|
|
2025
Q4 | $18.7M | Buy |
81,933
+43,897
| +115% | +$10M | 0.03% | 646 |
|
|
2025
Q3 | $8.81M | Buy |
38,036
+7,637
| +25% | +$1.56M | 0.01% | 960 |
|
|
2025
Q2 | $5.64M | Buy |
+30,399
| New | +$5.65M | 0.01% | 1140 |
|
|
2025
Q1 | – | Sell |
-46,553
| Closed | -$9.05M | – | 3979 |
|
|
2024
Q4 | $8.27M | Buy |
46,553
+10,915
| +31% | +$2.01M | 0.02% | 892 |
|
|
2024
Q3 | $7.04M | Sell |
35,638
-8,270
| -19% | -$1.54M | 0.01% | 942 |
|
|
2024
Q2 | $7.53M | Buy |
43,908
+21,579
| +97% | +$3.57M | 0.02% | 829 |
|
|
2024
Q1 | $4.07M | Buy |
22,329
+16,036
| +255% | +$2.76M | 0.01% | 1274 |
|
|
2023
Q4 | $975K | Sell |
6,293
-10,739
| -63% | -$1.57M | ﹤0.01% | 2486 |
|
|
2023
Q3 | $2.54M | Buy |
+17,032
| New | +$2.5M | 0.01% | 1602 |
|
|
2023
Q2 | – | Sell |
-69,433
| Closed | -$10.2M | – | 4647 |
|
|
2023
Q1 | $11.1M | Buy |
69,433
+47,895
| +222% | +$7.32M | 0.02% | 590 |
|
|
2022
Q4 | $3.48M | Sell |
21,538
-29,984
| -58% | -$4.6M | 0.01% | 1300 |
|
|
2022
Q3 | $6.92M | Buy |
51,522
+45,952
| +825% | +$6.59M | 0.02% | 814 |
|
|
2022
Q2 | $853K | Buy |
+5,570
| New | +$851K | ﹤0.01% | 2377 |
|
|
2021
Q3 | – | Sell |
-14,555
| Closed | -$1.66M | – | 5129 |
|
|
2021
Q2 | $1.64M | Buy |
14,555
+7,290
| +100% | +$821K | 0.01% | 1664 |
|
|
2021
Q1 | $786K | Sell |
7,265
-29,345
| -80% | -$3.14M | ﹤0.01% | 2164 |
|
|
2020
Q4 | $3.92M | Buy |
+36,610
| New | +$3.52M | 0.02% | 881 |
|
|
2019
Q3 | – | Sell |
-9,236
| Closed | -$633K | – | 3953 |
|
|
2019
Q2 | $672K | Buy |
+9,236
| New | +$726K | 0.01% | 1943 |
|
|
2018
Q2 | – | Sell |
-48,626
| Closed | -$4.75M | – | 4504 |
|
|
2018
Q1 | $4.6M | Buy |
48,626
+1,714
| +4% | +$188K | 0.03% | 584 |
|
|
2017
Q4 | $4.54K | Buy |
+46,912
| New | +$4.42M | 0.02% | 729 |
|
|
2016
Q1 | – | Sell |
-160,708
| Closed | -$8.96M | – | 5249 |
|
|
2015
Q4 | $9.52M | Buy |
160,708
+19,018
| +13% | +$1.1M | 0.09% | 202 |
|
|
2015
Q3 | $7.71M | Buy |
141,690
+31,967
| +29% | +$2.08M | 0.07% | 208 |
|
|
2015
Q2 | $7.37M | Sell |
109,723
-151,005
| -58% | -$9.86M | 0.07% | 209 |
|
|
2015
Q1 | $15.3M | Buy |
260,728
+212,241
| +438% | +$12.8M | 0.15% | 98 |
|
|
2014
Q4 | $3.17M | Buy |
+48,487
| New | +$3.06M | 0.03% | 470 |
|
|
2014
Q1 | – | Sell |
-40,445
| Closed | -$2.04M | – | 3466 |
|
|
2013
Q4 | $2.14M | Buy |
40,445
+27,347
| +209% | +$1.34M | 0.02% | 644 |
|
|
2013
Q3 | $586K | Buy |
13,098
+6,496
| +98% | +$288K | 0.01% | 1128 |
|
|
2013
Q2 | $273K | Buy |
+6,602
| New | +$289K | ﹤0.01% | 1554 |
|
Other funds holding ABBV
VCM
VPM
Walleye Trading's ABBV Position: Q1 2026 in Review
Walleye Trading reduced its AbbVie (ABBV) stake by 48% in Q1 2026, selling an estimated $8.81M and leaving 42,217 shares worth $9.18M. The position accounts for 0.02% of the portfolio, ranked #833.
Walleye Trading first reported a position in ABBV in Q2 2013 and has held it in 28 quarters since. The position peaked at $18.7M in Q4 2025. 4,076 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- Walleye Trading held 42,217 shares of AbbVie worth $9.18M as of Q1 2026.
- Walleye Trading sold 39,716 AbbVie shares in Q1 2026, an estimated $8.81M.
- AbbVie made up 0.02% of Walleye Trading's portfolio in Q1 2026, its #833 holding.
- Walleye Trading first reported a position in AbbVie in Q2 2013 and has held it in 28 quarters since.
- Walleye Trading's AbbVie position peaked at $18.7M in Q4 2025.
- 4,076 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on Walleye Trading's 13F filing for Q1 2026, filed 11 May 2026.